| Headline |
Date |
Article |
| MTTI will collaborate with Bexion to develop a novel nanovesicle for
molecular imaging of tumors. |
4/22/08 |
read more |
| MTTI and GENSEEN Partner to Develop Breast Cancer Gene Imaging Agent |
1/8/08 |
read more |
| MTTI Licenses Novel Research Product Lines from PTIR |
8/8/07 |
read more |
| Dr. Brian Gray Joins MTTI as Vice President of Research |
6/18/07 |
read more |
| MTTI Receives Grant to Advance its Pivotal Phase II Clinical Trial in Acute Coronary Syndrome |
5/8/07 |
read more |
Dominance of the Rabies Virus G Protein Carrying a Non-Pathogenic Determinant over
the G Protein Carrying a Pathogenic Determinant |
9/28/06 |
read more |
Identification of Pathogenicity Determinants of Rabies Virus (RV) and Assessment of the
Role of the Rate of Virus Replication/Transcription in Pathogenesis |
9/27/06 |
read more |
| MTTI Reports AMISCAN Phase II Clinical Results |
4/12/06 |
read more |
| Tc-99m glucarate tumor image featured on the cover of Medical Physics Journal |
4/6/06 |
read more |
| Chris Pak Speaks at the China TEDA Bioforum |
10/18/05 |
read more |
Evaluation of Prophylactic Efficacy of Human Anti-Rabies Monoclonal Antibodies
in Mouse Model |
9/30/05 |
read more |
| Characterization of Human Rabies Virus-Neutralizing Monoclonal Antibodies |
9/29/05 |
read more |
The Current Status of technetium-99m glucarate
for Evaluation of Acute Coronary Syndromes |
9/28/05 |
read more |
| Oral Vaccination of Skunks and Raccoons with Recombinant Rabies Virus Vaccines |
9/27/05 |
read more |
| A Single Amino Acid exchange with the G Protein of a Non-Pathogenic RV |
3/28/05 |
read more |
| Targeting of Human Lung-Cancer xenografts with Technetium-99m glucarate |
3/27/05 |
read more |
| Scintigraphy of 99mTc-D-glucaric acid in Multiple Myeloma Patients |
3/25/05 |
read more |
| Jefferson and MTTI Scientists Create New Vaccine for Wildlife Rabies |
12/9/04 |
read more |
| BTSCAN May Improve Detection of Drug-Resistant Breast Cancer |
11/28/03 |
read more |
| MTTI forms Partnership with North China Pharmaceutical Company |
9/18/03 |
read more |
| DRAXIS Commences Phase II Clinical Study for AMISCAN |
2/13/01 |
read more |
MTTI News